Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ADVANCE AUTO PARTS INCAAP · Entity 4323 | Director | April 03, 2020 | April 06, 2020 |
| AUTOLIV INCALV · Entity 3593 | Director | September 15, 2026 | September 17, 2026 |
| Aon plcAON · Entity 2608 | Director | June 25, 2026 | June 29, 2026 |
| BIOGEN INC.BIIB · Entity 1675 | EVP, Tech, Bus. Sol & Corp Aff | February 28, 2017 | March 02, 2017 |
| PERRIGO Co plcPRGO · Entity 4516 | Director | May 14, 2025 | May 16, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ADVANCE AUTO PARTS INC
Report date April 03, 2020 · Filed April 06, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 5,445.476 |
Reported balance
After 2020-04-03 transaction · row 1
1 source rowRow 1 · 2020-04-03 · Grant · Acquired 14.955 · Balance 5,445.476 F1: These shares of issuer common stock were acquired pursuant to a dividend reinvestment feature of the Advance Auto Parts, Inc. Deferred Stock Unit Plan for Non-Employee Directors and Selected Executives. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares of issuer common stock were acquired pursuant to a dividend reinvestment feature of the Advance Auto Parts, Inc. Deferred Stock Unit Plan for Non-Employee Directors and Selected Executives.
AUTOLIV INC
Report date September 15, 2026 · Filed September 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Restricted Stock UnitSEC Table II · derivative / convertible security | Direct | 1,425.1232 |
Reported balance
After 2026-09-15 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-09-15 · Grant · Acquired 10.5907 · Balance 1,425.1232 F1: Each RSU represents a contingent right to receive one share of ALV common stock. F2: Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs. F3: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2027 annual stockholder meeting, or (b) the one-year anniversary of May 7, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: Each RSU represents a contingent right to receive one share of ALV common stock.
F2: Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs.
F3: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2027 annual stockholder meeting, or (b) the one-year anniversary of May 7, 2026.
Aon plc
Report date June 25, 2026 · Filed June 29, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Ordinary StockSEC Table I · non-derivative | Direct | 2,605.735 |
Ending reported balance
After 2026-06-25 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2026-06-25 · Grant · Acquired 776 · Balance 2,791.97 F1: Class A Ordinary Shares granted annually to each non-employee director of Aon plc. In accordance with Irish law, reporting person agreed to pay the issuer the nominal value of US $0.01 per share issued to the reporting person. Row 2 · 2026-06-25 · Tax withholding · Disposed 186.235 · Balance 2,605.735 F2: Class A Ordinary Shares withheld by the issuer for payment of taxes in connection with the award. |
Filing footnotes · ownership attribution and instrument terms
F1: Class A Ordinary Shares granted annually to each non-employee director of Aon plc. In accordance with Irish law, reporting person agreed to pay the issuer the nominal value of US $0.01 per share issued to the reporting person.
F2: Class A Ordinary Shares withheld by the issuer for payment of taxes in connection with the award.
BIOGEN INC.
Report date February 28, 2017 · Filed March 02, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 8,752 |
Ending reported balance
After 2017-02-28 transaction · row 4
4 source rows · reconciled sequenceRow 1 · 2017-02-28 · Exercise / conversion · Acquired 570 · Balance 7,996 F1: This award vested on 2/23/2017 and the actual number of shares that vested was determined in accordance with the terms of such award. Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017. Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017. Row 2 · 2017-02-28 · Tax withholding · Disposed 253 · Balance 7,743 F1: This award vested on 2/23/2017 and the actual number of shares that vested was determined in accordance with the terms of such award. Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017. Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017. Row 3 · 2017-02-28 · Exercise / conversion · Acquired 1,494 · Balance 9,237 F2: This award vested on 2/22/2017 and the actual number of shares that vested was determined in accordance with the terms of such award. Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017. Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017. Row 4 · 2017-02-28 · Tax withholding · Disposed 485 · Balance 8,752 F2: This award vested on 2/22/2017 and the actual number of shares that vested was determined in accordance with the terms of such award. Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017. Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017. |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2019-02-22 | Direct | 6,886 |
Reported balance
After 2017-02-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-02-28 · Other · Disposed 1,198 · Balance 6,886 F3: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number of shares that vested. F4: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]). |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2018-02-23 | Direct | 2,092 |
Reported balance
After 2017-02-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-02-28 · Other · Disposed 952 · Balance 2,092 F3: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number of shares that vested. F5: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]). |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2018-02-23 | Direct | 1,522 |
Reported balance
After 2017-02-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-02-28 · Exercise / conversion · Disposed 570 · Balance 1,522 F1: This award vested on 2/23/2017 and the actual number of shares that vested was determined in accordance with the terms of such award. Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017. Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017. F6: This award was previously reported as covering 2,974 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017. F5: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]). |
| Restricted Stock UnitSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 · Expires 2019-02-22 | Direct | 5,392 |
Reported balance
After 2017-02-28 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-02-28 · Exercise / conversion · Disposed 1,494 · Balance 5,392 F2: This award vested on 2/22/2017 and the actual number of shares that vested was determined in accordance with the terms of such award. Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017. Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017. F7: This award was previously reported as covering 7,900 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017. F4: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]). |
Filing footnotes · ownership attribution and instrument terms
F1: This award vested on 2/23/2017 and the actual number of shares that vested was determined in accordance with the terms of such award. Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017. Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017.
F2: This award vested on 2/22/2017 and the actual number of shares that vested was determined in accordance with the terms of such award. Due to adjustments to the award to account for the Bioverativ Inc. spin-off, the number of vested shares was not determinable until 2/28/2017. Such adjusted number of vested shares was distributed to the reporting person on 2/28/2017.
F3: This represents the difference between the maximum possible number of shares that were eligible for vesting and the actual number of shares that vested.
F4: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).
F5: The number of RSUs reported represents the maximum possible number of shares that are eligible for vesting, which is 200% of the number of shares at target payout. One-third of these RSUs are eligible to vest on each of the first three anniversaries of the grant date. The actual number of shares that will vest on each vesting date will be determined by comparing the price of Biogen common stock on such vesting date to the price on the grant date (i.e., number of vested shares = number of shares at target payout times [the 30-day average closing stock price ending on the vesting date divided by the 30-day average closing stock price on the grant date]).
F6: This award was previously reported as covering 2,974 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017.
F7: This award was previously reported as covering 7,900 shares, but was adjusted pursuant to the anti-dilution provisions of the award in connection with the spin-off of Bioverativ Inc. on February 1, 2017.
PERRIGO Co plc
Report date May 14, 2025 · Filed May 16, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 27,629 |
Ending reported balance
After 2025-05-14 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2025-05-14 · Exercise / conversion · Acquired 9,904 · Balance 32,383 Row 2 · 2025-05-14 · Tax withholding · Disposed 4,754 · Balance 27,629 |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 7,305 |
Reported balance
After 2025-05-14 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2025-05-14 · Grant · Acquired 7,305 · Balance 7,305 F1: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2026. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2025-05-14 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2025-05-14 · Exercise / conversion · Disposed 9,904 · Balance 0 F1: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share.
F2: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2026.
F3: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ASPENTECH Corp
Report date May 16, 2022 · Filed May 18, 2022
Section 16 reporting ended · disclosed 2022-05-18. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Ending reported balance
After 2022-05-16 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2022-05-16 · Disposition to issuer · Disposed 2,229 · Balance 419 F1: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. F2: At the effective time of the Merger (the "Effective Time"), each outstanding share of the AspenTech common stock (other than certain excluded shares) automatically converted into the right to receive $87.69 in cash (the "Cash Consideration"), plus 0.42 of a validly issued, fully paid and nonassessable share of New AspenTech. Row 2 · 2022-05-16 · Disposition to issuer · Disposed 419 · Balance 0 F1: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. F3: Reflects restricted stock units ("RSUs"). Each unvested RSU outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive an award of RSUs covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (x) the number of shares of AspenTech common stock underlying such AspenTech RSU award and (y) the sum of (i) 0.42 and (ii) the quotient obtained by dividing (xx) $87.69 by (yy) the volume-weighted average price per share of the New AspenTech common stock on Nasdaq during the five trading days after the Effective Time (the sum obtained under clause (y), the "Aspen Equity Award Exchange Ratio"). F4: Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time. |
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $97.00 · Expires 2030-07-21 | Direct | 0 |
Reported balance
After 2022-05-16 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2022-05-16 · Disposition to issuer · Disposed 1,983 · Balance 0 F1: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. F4: Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time. F6: Each AspenTech stock option ("AspenTech Stock Option") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option ("Converted Option") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent. F5: One third of the options granted at the exercise price of $97.00 will vest on the first anniversary of the grant and the remainder will vest in eight equal consecutive quarterly installments on the last business day of the quarter until fully vested. |
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $129.50 · Expires 2031-08-31 | Direct | 0 |
Reported balance
After 2022-05-16 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2022-05-16 · Disposition to issuer · Disposed 1,443 · Balance 0 F1: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. F4: Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time. F6: Each AspenTech stock option ("AspenTech Stock Option") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option ("Converted Option") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent. F7: The option granted at the exercise price of $129.50 was fully vested on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech.
F2: At the effective time of the Merger (the "Effective Time"), each outstanding share of the AspenTech common stock (other than certain excluded shares) automatically converted into the right to receive $87.69 in cash (the "Cash Consideration"), plus 0.42 of a validly issued, fully paid and nonassessable share of New AspenTech.
F3: Reflects restricted stock units ("RSUs"). Each unvested RSU outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive an award of RSUs covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (x) the number of shares of AspenTech common stock underlying such AspenTech RSU award and (y) the sum of (i) 0.42 and (ii) the quotient obtained by dividing (xx) $87.69 by (yy) the volume-weighted average price per share of the New AspenTech common stock on Nasdaq during the five trading days after the Effective Time (the sum obtained under clause (y), the "Aspen Equity Award Exchange Ratio").
F4: Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time.
F5: One third of the options granted at the exercise price of $97.00 will vest on the first anniversary of the grant and the remainder will vest in eight equal consecutive quarterly installments on the last business day of the quarter until fully vested.
F6: Each AspenTech stock option ("AspenTech Stock Option") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option ("Converted Option") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent.
F7: The option granted at the exercise price of $129.50 was fully vested on the date of grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 15, 2026 Filed Sep 17, 2026 11:00 UTC | AUTOLIV INC ALV · Entity 3593 | GrantRestricted Stock Unit · Derivative | 10.5907 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-393723 · ownership.xml · derivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,425.1232 Underlying: Common Stock · 10.5907 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of ALV common stock. F2 · kind: Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs. F3 · derivative.exercise_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2027 annual stockholder meeting, or (b) the one-year anniversary of May 7, 2026. F3 · derivative.expiration_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2027 annual stockholder meeting, or (b) the one-year anniversary of May 7, 2026. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:16 UTC | Aon plc AON · Entity 2608 | Tax withholdingClass A Ordinary Stock | 186.235 | $315.95 | $58,840.95 |
DisclosureSEC source: 0001193125-26-288734 · ownership.xml · nonDerivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,605.735 F2 · kind: Class A Ordinary Shares withheld by the issuer for payment of taxes in connection with the award. Read SEC document |
| June 25, 2026 Filed Jun 29, 2026 21:16 UTC | Aon plc AON · Entity 2608 | GrantClass A Ordinary Stock | 776 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001193125-26-288734 · ownership.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,791.97 F1 · kind: Class A Ordinary Shares granted annually to each non-employee director of Aon plc. In accordance with Irish law, reporting person agreed to pay the issuer the nominal value of US $0.01 per share issued to the reporting person. F1 · price: Class A Ordinary Shares granted annually to each non-employee director of Aon plc. In accordance with Irish law, reporting person agreed to pay the issuer the nominal value of US $0.01 per share issued to the reporting person. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 11:30 UTC | AUTOLIV INC ALV · Entity 3593 | GrantRestricted Stock Unit · Derivative | 9.5325 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-264906 · ownership.xml · derivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,414.5325 Underlying: Common Stock · 9.5325 shares Expires not disclosed F1 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of ALV common stock. F2 · kind: Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs. F3 · derivative.exercise_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2027 annual stockholder meeting, or (b) the one-year anniversary of May 7, 2026. F3 · derivative.expiration_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2027 annual stockholder meeting, or (b) the one-year anniversary of May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 11, 2026 14:30 UTC | AUTOLIV INC ALV · Entity 3593 | GrantRestricted Stock Unit · Derivative | 1,405 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-216002 · ownership.xml · derivative · entry 3 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,405 Underlying: Common Stock · 1,405 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of ALV common stock. F4 · kind: Reflects a grant of RSUs as part of the 2026-2027 annual retainer for non-employee director service. F5 · derivative.exercise_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2027 annual stockholder meeting, or (b) the one-year anniversary of May 7, 2026. F5 · derivative.expiration_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2027 annual stockholder meeting, or (b) the one-year anniversary of May 7, 2026. Read SEC document |
| May 07, 2026 Filed May 11, 2026 14:30 UTC | AUTOLIV INC ALV · Entity 3593 | Exercise / conversionRestricted Stock Unit · Derivative | 1,756.0112 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-216002 · ownership.xml · derivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,756.0112 shares Expires 2026-05-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of ALV common stock. F1 · kind: Reflects the vesting of restricted stock units (RSUs) granted on May 8, 2025 as part of the 2025-2026 annual retainer for non-employee director service. F3 · shares: Fractional RSUs are rounded down to the nearest whole number at vesting, the fractional amount is forfeited. Read SEC document |
| May 07, 2026 Filed May 11, 2026 14:30 UTC | AUTOLIV INC ALV · Entity 3593 | Exercise / conversionCommon Stock | 1,756 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-216002 · ownership.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,844 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the vesting of restricted stock units (RSUs) granted on May 8, 2025 as part of the 2025-2026 annual retainer for non-employee director service. Read SEC document |
| March 19, 2026 Filed Mar 23, 2026 11:00 UTC | AUTOLIV INC ALV · Entity 3593 | GrantRestricted Stock Unit · Derivative | 14.8887 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-26-118501 · ownership.xml · derivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,756.0112 Underlying: Common Stock · 14.8887 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of ALV common stock. F2 · kind: Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs. F3 · derivative.exercise_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2026 annual stockholder meeting, or (b) the one-year anniversary of May 8, 2025. F3 · derivative.expiration_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2026 annual stockholder meeting, or (b) the one-year anniversary of May 8, 2025. Read SEC document |
| December 10, 2025 Filed Dec 11, 2025 16:00 UTC | AUTOLIV INC ALV · Entity 3593 | GrantRestricted Stock Unit · Derivative | 12.5458 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-315366 · ownership.xml · derivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,741.1225 Underlying: Common Stock · 12.5458 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of ALV common stock. F2 · kind: Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs. F3 · derivative.exercise_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2026 annual stockholder meeting, or (b) the one-year anniversary of May 8, 2025. F3 · derivative.expiration_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2026 annual stockholder meeting, or (b) the one-year anniversary of May 8, 2025. Read SEC document |
| September 23, 2025 Filed Sep 24, 2025 14:00 UTC | AUTOLIV INC ALV · Entity 3593 | GrantRestricted Stock Unit · Derivative | 11.5121 | $0.00 | $0.00 |
DisclosureSEC source: 0001193125-25-214387 · ownership.xml · derivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,728.5767 Underlying: Common Stock · 11.5121 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of ALV common stock. F2 · kind: Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs. F3 · derivative.exercise_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2026 annual stockholder meeting, or (b) the one-year anniversary of May 8, 2025. F3 · derivative.expiration_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2026 annual stockholder meeting, or (b) the one-year anniversary of May 8, 2025. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 21:12 UTC | Aon plc AON · Entity 2608 | Tax withholdingClass A Ordinary Stock | 152.876 | $353.55 | $54,049.31 |
DisclosureSEC source: 0000950170-25-091717 · ownership.xml · nonDerivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,015.97 F2 · kind: Class A Ordinary Shares withheld by the issuer for payment of taxes in connection with the award. Read SEC document |
| June 26, 2025 Filed Jun 30, 2025 21:12 UTC | Aon plc AON · Entity 2608 | GrantClass A Ordinary Stock | 637 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-25-091717 · ownership.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,168.846 F1 · kind: Class A Ordinary Shares granted annually to each non-employee director of Aon plc. In accordance with Irish law, reporting person agreed to pay the issuer the nominal value of US $0.01 per share issued to the reporting person. F1 · price: Class A Ordinary Shares granted annually to each non-employee director of Aon plc. In accordance with Irish law, reporting person agreed to pay the issuer the nominal value of US $0.01 per share issued to the reporting person. Read SEC document |
| June 10, 2025 Filed Jun 11, 2025 14:30 UTC | AUTOLIV INC ALV · Entity 3593 | GrantRestricted Stock Unit · Derivative | 11.0646 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-084705 · ownership.xml · derivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,717.0646 Underlying: Common Stock · 11.0646 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of ALV common stock. F2 · kind: Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs. F3 · derivative.exercise_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2026 annual stockholder meeting, or (b) the one-year anniversary of May 8, 2025. F3 · derivative.expiration_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2026 annual stockholder meeting, or (b) the one-year anniversary of May 8, 2025. Read SEC document |
| May 14, 2025 Filed May 16, 2025 15:52 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 9,904 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-25-000072 · wk-form4_1747410725.xml · derivative · entry 4 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 9,904 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025. F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025. Read SEC document |
| May 14, 2025 Filed May 16, 2025 15:52 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | 7,305 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-25-000072 · wk-form4_1747410725.xml · derivative · entry 3 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,305 Underlying: Ordinary Shares · 7,305 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2026. Read SEC document |
| May 14, 2025 Filed May 16, 2025 15:52 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 4,754 | $26.01 | $123,651.54 |
DisclosureSEC source: 0001585364-25-000072 · wk-form4_1747410725.xml · nonDerivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,629 Read SEC document |
| May 14, 2025 Filed May 16, 2025 15:52 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 9,904 | $26.01 | $257,603.04 |
DisclosureSEC source: 0001585364-25-000072 · wk-form4_1747410725.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,383 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 08, 2025 Filed May 12, 2025 12:00 UTC | AUTOLIV INC ALV · Entity 3593 | GrantRestricted Stock Unit · Derivative | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-068589 · ownership.xml · derivative · entry 3 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,706 Underlying: Common Stock · 1,706 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of ALV common stock. F4 · kind: Reflects a grant of RSUs as part of the 2025-2026 annual retainer for non-employee director service. F5 · derivative.exercise_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2026 annual stockholder meeting, or (b) the one-year anniversary of May 8, 2025. F5 · derivative.expiration_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2026 annual stockholder meeting, or (b) the one-year anniversary of May 8, 2025. Read SEC document |
| May 08, 2025 Filed May 12, 2025 12:00 UTC | AUTOLIV INC ALV · Entity 3593 | Exercise / conversionRestricted Stock Unit · Derivative | 1,088.4117 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-068589 · ownership.xml · derivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,088.4117 shares Expires 2025-05-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each RSU represents a contingent right to receive one share of ALV common stock. F1 · kind: Reflects the vesting of restricted stock units (RSUs) granted on September 13, 2024 as part of the 2024-2025 annual retainer for non-employee director service. F3 · shares: Fractional RSUs are rounded down to the nearest whole number at vesting, the fractional amount is forfeited. Read SEC document |
| May 08, 2025 Filed May 12, 2025 12:00 UTC | AUTOLIV INC ALV · Entity 3593 | Exercise / conversionCommon Stock | 1,088 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-068589 · ownership.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,088 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Reflects the vesting of restricted stock units (RSUs) granted on September 13, 2024 as part of the 2024-2025 annual retainer for non-employee director service. Read SEC document |
| March 24, 2025 Filed Mar 26, 2025 12:00 UTC | AUTOLIV INC ALV · Entity 3593 | GrantRestricted Stock Unit · Derivative | 8.1959 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-25-044794 · ownership.xml · derivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,088.4177 Underlying: Common Stock · 8.1959 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of ALV common stock. F2 · kind: Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs. F3 · derivative.exercise_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2025 annual stockholder meeting, or (b) the one-year anniversary of May 10, 2024. F3 · derivative.expiration_date: The RSUs vest and convert to shares in one installment on the earlier of (a) the date of ALV's 2025 annual stockholder meeting, or (b) the one-year anniversary of May 10, 2024. Read SEC document |
| December 19, 2024 Filed Dec 20, 2024 17:00 UTC | AUTOLIV INC ALV · Entity 3593 | GrantRestricted Stock Unit · Derivative | 8.2218 | $0.00 | $0.00 |
DisclosureSEC source: 0000950170-24-138903 · ownership.xml · derivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,080.2218 Underlying: Common Stock · 8.2218 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit (RSU) represents a contingent right to receive one share of ALV common stock. F2 · kind: Dividend equivalent rights accrued in the form of additional RSUs. Per the award agreement, cash dividends with a record date on or after the grant date and paid on or before the vesting date yield additional RSUs subject to the same vesting schedule as the underlying RSUs. F3 · derivative.exercise_date: The RSUs vest and convert to shares in one installment on the date of ALV's 2025 annual stockholder meeting. F3 · derivative.expiration_date: The RSUs vest and convert to shares in one installment on the date of ALV's 2025 annual stockholder meeting. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 20:38 UTC | Aon plc AON · Entity 2608 | Tax withholdingClass A Ordinary Stock | 182.154 | $296.59 | $54,025.05 |
DisclosureSEC source: 0000950170-24-076791 · ownership.xml · nonDerivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,531.846 F2 · kind: Class A Ordinary Shares withheld by the issuer for payment of taxes in connection with the award. Read SEC document |
| June 20, 2024 Filed Jun 24, 2024 20:38 UTC | Aon plc AON · Entity 2608 | GrantClass A Ordinary Stock | 759 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000950170-24-076791 · ownership.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,714 F1 · kind: Class A Ordinary Shares granted annually to each non-employee director of Aon plc. In accordance with Irish law, reporting person agreed to pay the issuer the nominal value of US $0.01 per share issued to the reporting person. F1 · price: Class A Ordinary Shares granted annually to each non-employee director of Aon plc. In accordance with Irish law, reporting person agreed to pay the issuer the nominal value of US $0.01 per share issued to the reporting person. Read SEC document |
| May 15, 2024 Filed May 16, 2024 23:26 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 8,764 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-24-000084 · wk-form4_1715902006.xml · derivative · entry 4 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,764 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024. F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024. Read SEC document |
| May 15, 2024 Filed May 16, 2024 23:26 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 4,207 | $30.22 | $127,135.54 |
DisclosureSEC source: 0001585364-24-000084 · wk-form4_1715902006.xml · nonDerivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,479 Read SEC document |
| May 15, 2024 Filed May 16, 2024 23:26 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 8,764 | $30.22 | $264,848.08 |
DisclosureSEC source: 0001585364-24-000084 · wk-form4_1715902006.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,686 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 14, 2024 Filed May 16, 2024 23:26 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | 9,904 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-24-000084 · wk-form4_1715902006.xml · derivative · entry 3 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,904 Underlying: Ordinary Shares · 9,904 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025. F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 14 May 2025. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 20:28 UTC | Aon plc AON · Entity 2608 | Tax withholdingClass A Ordinary Stock | 177 | $331.06 | $58,597.62 |
DisclosureSEC source: 0001209191-23-038400 · doc4.xml · nonDerivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 955 F2 · kind: Class A Ordinary Shares withheld by the issuer for payment of taxes in connection with the award. Read SEC document |
| June 15, 2023 Filed Jun 20, 2023 20:28 UTC | Aon plc AON · Entity 2608 | GrantClass A Ordinary Stock | 635 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-038400 · doc4.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,132 F1 · kind: Class A Ordinary Shares granted annually to each non-employee director of Aon plc. In accordance with Irish law, reporting person agreed to pay the issuer the nominal value of US $0.01 per share issued to the reporting person. F1 · price: Class A Ordinary Shares granted annually to each non-employee director of Aon plc. In accordance with Irish law, reporting person agreed to pay the issuer the nominal value of US $0.01 per share issued to the reporting person. Read SEC document |
| May 17, 2023 Filed May 19, 2023 18:38 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 7,778 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-23-000095 · wf-form4_168452147238974.xml · derivative · entry 3 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 7,778 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · kind: Vesting of service-based restricted stock units granted on 17 May 2022. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023. F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023. Read SEC document |
| May 17, 2023 Filed May 19, 2023 18:38 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 3,734 | $32.86 | $122,699.24 |
DisclosureSEC source: 0001585364-23-000095 · wf-form4_168452147238974.xml · nonDerivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 17,922 Read SEC document |
| May 17, 2023 Filed May 19, 2023 18:38 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 7,778 | $32.86 | $255,585.08 |
DisclosureSEC source: 0001585364-23-000095 · wf-form4_168452147238974.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,656 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of service-based restricted stock units granted on 17 May 2022. Read SEC document |
| May 15, 2023 Filed May 17, 2023 19:41 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | 8,764 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-23-000078 · wf-form4_168435249493630.xml · derivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,764 Underlying: Ordinary Shares · 8,764 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024. F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 15 May 2024. Read SEC document |
| November 18, 2022 Filed Nov 22, 2022 21:58 UTC | Aon plc AON · Entity 2608 | GrantClass A Ordinary Stock | 497 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-22-058419 · doc4.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497 F1 · kind: Class A Ordinary Shares granted annually to each non-employee director of Aon plc. In connection with the election of Ms. Adriana Karaboutis as a director of Aon plc effective September 8, 2022, the Board of Directors granted fully vested Aon plc Class A Ordinary Shares to Ms. Karaboutis to reflect pro-ration for the period of service from September 8, 2022 through June 16, 2023. In accordance with Irish law, reporting person agreed to pay the issuer the nominal value of US $0.01 per share issued to the reporting person. F1 · price: Class A Ordinary Shares granted annually to each non-employee director of Aon plc. In connection with the election of Ms. Adriana Karaboutis as a director of Aon plc effective September 8, 2022, the Board of Directors granted fully vested Aon plc Class A Ordinary Shares to Ms. Karaboutis to reflect pro-ration for the period of service from September 8, 2022 through June 16, 2023. In accordance with Irish law, reporting person agreed to pay the issuer the nominal value of US $0.01 per share issued to the reporting person. Read SEC document |
| May 17, 2022 Filed May 19, 2022 17:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 6,599 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-22-000059 · wf-form4_165298288584876.xml · derivative · entry 4 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,599 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · kind: Vesting of service-based restricted stock units granted on 17 May 2021. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F4 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2022. F4 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2022. Read SEC document |
| May 17, 2022 Filed May 19, 2022 17:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | 7,778 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-22-000059 · wf-form4_165298288584876.xml · derivative · entry 3 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,778 Underlying: Ordinary Shares · 7,778 shares Expires not disclosed F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023. F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 17 May 2023. Read SEC document |
| May 17, 2022 Filed May 19, 2022 17:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 3,168 | $38.57 | $122,189.76 |
DisclosureSEC source: 0001585364-22-000059 · wf-form4_165298288584876.xml · nonDerivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,878 Read SEC document |
| May 17, 2022 Filed May 19, 2022 17:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 6,599 | $38.57 | $254,523.43 |
DisclosureSEC source: 0001585364-22-000059 · wf-form4_165298288584876.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,046 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of service-based restricted stock units granted on 17 May 2021. Read SEC document |
| May 16, 2022 Filed May 18, 2022 16:42 UTC | ASPENTECH Corp AZPN · Entity 127212 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 1,443 | Not disclosed Strike: $129.50 | Not disclosed |
DisclosureSEC source: 0001127602-22-014972 · form4.xml · derivative · entry 4 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,443 shares Expires 2031-08-31 F1 · kind: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. F4 · price: Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time. F6 · price: Each AspenTech stock option ("AspenTech Stock Option") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option ("Converted Option") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent. F7 · derivative.exercise_date: The option granted at the exercise price of $129.50 was fully vested on the date of grant. Read SEC document |
| May 16, 2022 Filed May 18, 2022 16:42 UTC | ASPENTECH Corp AZPN · Entity 127212 | Disposition to issuerDirector Stock Option (Right to Buy) · Derivative | 1,983 | Not disclosed Strike: $97.00 | Not disclosed |
DisclosureSEC source: 0001127602-22-014972 · form4.xml · derivative · entry 3 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 1,983 shares Expires 2030-07-21 F1 · kind: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. F4 · price: Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time. F6 · price: Each AspenTech stock option ("AspenTech Stock Option") outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive a New AspenTech stock option ("Converted Option") covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (i) the number of shares of AspenTech common stock underlying the corresponding AspenTech Stock Option as of immediately prior to the Effective Time multiplied by (ii) the Aspen Equity Award Exchange Ratio. The exercise price applicable to each Converted Option shall be equal to (i) the exercise price per share of AspenTech common stock applicable to the corresponding AspenTech Stock Option as of immediately prior to the Effective Time divided by (ii) the Aspen Equity Award Exchange Ratio, rounded up to the nearest whole cent. F5 · derivative.exercise_date: One third of the options granted at the exercise price of $97.00 will vest on the first anniversary of the grant and the remainder will vest in eight equal consecutive quarterly installments on the last business day of the quarter until fully vested. Read SEC document |
| May 16, 2022 Filed May 18, 2022 16:42 UTC | ASPENTECH Corp AZPN · Entity 127212 | Disposition to issuerCommon Stock | 419 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-014972 · form4.xml · nonDerivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. F3 · price: Reflects restricted stock units ("RSUs"). Each unvested RSU outstanding immediately prior to the Effective Time was cancelled and assumed by New AspenTech and converted into the right to receive an award of RSUs covering that number of shares of New AspenTech common stock, rounded down to the nearest whole share, equal to the product of (x) the number of shares of AspenTech common stock underlying such AspenTech RSU award and (y) the sum of (i) 0.42 and (ii) the quotient obtained by dividing (xx) $87.69 by (yy) the volume-weighted average price per share of the New AspenTech common stock on Nasdaq during the five trading days after the Effective Time (the sum obtained under clause (y), the "Aspen Equity Award Exchange Ratio"). F4 · price: Each converted equity award described herein shall be subject to the same terms and conditions (including vesting and expiration schedule, as applicable) as applied to the corresponding AspenTech equity award as of immediately prior to the Effective Time. Read SEC document |
| May 16, 2022 Filed May 18, 2022 16:42 UTC | ASPENTECH Corp AZPN · Entity 127212 | Disposition to issuerCommon Stock | 2,229 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-22-014972 · form4.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419 F1 · kind: On May 16, 2022, the closing of the transactions contemplated by the Transaction Agreement and Plan of Merger, dated as of October 10, 2021, as amended, among Aspen Technology, Inc. ("AspenTech"), Emerson Electric Co., Emersub CX, Inc., ("New AspenTech") and certain other parties, occurred, pursuant to which AspenTech merged with a wholly owned subsidiary of New AspenTech (the "Merger"). Pursuant to the Merger, AspenTech became a wholly owned subsidiary of New AspenTech. F2 · price: At the effective time of the Merger (the "Effective Time"), each outstanding share of the AspenTech common stock (other than certain excluded shares) automatically converted into the right to receive $87.69 in cash (the "Cash Consideration"), plus 0.42 of a validly issued, fully paid and nonassessable share of New AspenTech. Read SEC document |
| May 12, 2022 Filed May 13, 2022 16:57 UTC | ASPENTECH Corp AZPN · Entity 127212 | GrantCommon Stock | 826 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-22-014474 · form4.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,648 F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. The Restricted Stock Units were fully vested on the date of grant. F2 · price: The Restricted Stock Units were received as a grant for no consideration. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 16:23 UTC | ASPENTECH Corp AZPN · Entity 127212 | GrantDirector Stock Option (Right to Buy) · Derivative | 1,443 | $129.50 Strike: $129.50 | $186,868.50 |
DisclosureSEC source: 0001127602-21-024886 · form4.xml · derivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,443 Underlying: Common Stock · 1,443 shares Expires 2031-08-31 F3 · derivative.exercise_date: The option granted at the exercise price of $129.50 was fully vested on the date of grant. Read SEC document |
| September 01, 2021 Filed Sep 3, 2021 16:23 UTC | ASPENTECH Corp AZPN · Entity 127212 | GrantCommon Stock | 816 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-21-024886 · form4.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,822 F1 · security: Each Restricted Stock Unit represents a contingent right to receive one share of Aspen Technology, Inc. common stock. The Restricted Stock Units were fully vested on the date of grant. F2 · price: The Restricted Stock Units were received as a grant for no consideration. Read SEC document |
| May 17, 2021 Filed May 19, 2021 16:57 UTC | PERRIGO Co plc PRGO · Entity 4516 | GrantRestricted Stock Units · Derivative | 6,599 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000079 · wf-form4_162144344972458.xml · derivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,599 Underlying: Ordinary Shares · 6,599 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F2 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 17 May 2022. F2 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting in 3 equal annual installments beginning 17 May 2022. Read SEC document |
| May 07, 2021 Filed May 11, 2021 18:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionRestricted Stock Units · Derivative | 5,804 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001585364-21-000056 · wf-form4_162075932984589.xml · derivative · entry 3 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,804 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F1 · kind: Vesting of service-based restricted stock units granted on 7 May 2020. F2 · price: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. F3 · derivative.exercise_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021. F3 · derivative.expiration_date: Each Restricted Stock Unit represents a contingent right to receive one Perrigo Company plc ordinary share. Vesting on 7 May 2021. Read SEC document |
| May 07, 2021 Filed May 11, 2021 18:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Tax withholdingOrdinary Shares | 2,786 | $42.96 | $119,686.56 |
DisclosureSEC source: 0001585364-21-000056 · wf-form4_162075932984589.xml · nonDerivative · entry 2 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,447 Read SEC document |
| May 07, 2021 Filed May 11, 2021 18:55 UTC | PERRIGO Co plc PRGO · Entity 4516 | Exercise / conversionOrdinary Shares | 5,804 | $42.96 | $249,339.84 |
DisclosureSEC source: 0001585364-21-000056 · wf-form4_162075932984589.xml · nonDerivative · entry 1 Karaboutis Adriana · CIK 0001619963 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,233 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Vesting of service-based restricted stock units granted on 7 May 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.